Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 49 | ECE2017 | Next issue

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

Card image cap
20-23 May 2017, Lisbon, Portugal Further information

Guided Posters

Pituitary

Previous section
Obesity
Table of contents
Next section
Pituitary & endocrine Tumours

ea0049gp173 | Pituitary

A comparison of single-dose effects of short acting somatostatin analogs: octreotide vs pasireotide in patients with active acromegaly after surgical debulking

ea0049gp174 | Pituitary

Efficacy and safety of switching to pasireotide LAR alone or in combination with pegvisomant in acromegaly patients controlled with combination treatment of first-generation somatostatin analogues and weekly pegvisomant (PAPE study): a prospective open-label 48 week study, preliminary results 24 weeks

ea0049gp175 | Pituitary

Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients

ea0049gp176 | Pituitary

Minimally Invasive Diagnosis and Direct Transnasal Surgery: a single centre series of 100 children with Cushing’s Disease with long term follow-up

ea0049gp177 | Pituitary

Octreotide subcutaneous (s.c.) depot, a novel ready-to-use formulation, provides higher exposure and maintains response in patients with acromegaly and functioning neuroendocrine tumours (NETs) previously treated with long-acting octreotide: Results from a phase 2, open-label, multicentre, randomized study

ea0049gp178 | Pituitary

Sleep patterns in patients with non-functional GHRH receptor

ea0049gp179 | Pituitary

Correction of sustained hyponatremia secondary to SIAD by the use of chronic tolvaptan therapy is associated with a reduction in Emergency Room visits, hospital admissions and days of hospitalization over a 3-year period

ea0049gp180 | Pituitary

Outcome of non-functioning pituitary adenomas that regrow after primary treatment: a study from two large specialist UK centers

ea0049gp181 | Pituitary

Targeting either GH or IGF-I levels during somatostatin analogue treatment in patients with acromegaly: A randomized, investigator-initiated multicenter study

ea0049gp182 | Pituitary

Brain white matter damage and volumes of hippocampus and hypothalamus correlates to cognitive function in craniopharyngioma

ea0049gp183 | Pituitary

Copeptin – a sensitive marker of an altered CRH-axis in pituitary disease

ea0049gp184 | Pituitary

Hormonal and metabolic effects of long-term cabergoline withdrawal in patients with hyperprolactinemia

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more